Axsome Therapeutics (AXSM) EPS (Basic) (2015 - 2026)
Axsome Therapeutics recorded quarterly EPS (Basic) of -$1.26 in Q1 2026, down 129.09% quarter-over-quarter from -$0.55 in Q4 2025, and down 3.28% year-over-year from -$1.3 in Q1 2025.
Axsome Therapeutics' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$1.26 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 3.28% year-over-year to -$1.26; the TTM figure through Mar 2026 stood at -$3.72 (up 35.53% YoY), while the FY2025 annual figure was -$3.68, up 38.56% from the prior year.
- EPS (Basic) came in at -$1.26 for Q1 2026 at Axsome Therapeutics, down from -$0.55 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.26 in Q1 2023 to a low of -$2.13 in Q4 2023.
- A 5-year average of -$1.22 and a median of -$1.26 in 2026 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) soared 75.47% in 2023 and plunged 453.85% in 2024, its largest moves.
- Axsome Therapeutics' EPS (Basic) stood at -$1.43 in 2022, then tumbled by 48.95% to -$2.13 in 2023, then grew by 27.7% to -$1.54 in 2024, then surged by 64.29% to -$0.55 in 2025, then plunged by 129.09% to -$1.26 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.26, -$0.55, and -$0.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -1.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.26 |
| Dec 31, 2025 | -0.55 |
| Sep 30, 2025 | -0.94 |
| Jun 30, 2025 | -0.97 |
| Mar 31, 2025 | -1.22 |
| Dec 31, 2024 | -1.54 |
| Sep 30, 2024 | -1.34 |
| Jun 30, 2024 | -1.67 |
| Mar 31, 2024 | -1.44 |
| Dec 31, 2023 | -2.13 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -1.54 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | -1.43 |
| Sep 30, 2022 | -1.07 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -1.06 |
| Dec 31, 2021 | -0.90 |
| Sep 30, 2021 | -0.93 |
| Jun 30, 2021 | -0.86 |
| Mar 31, 2021 | -0.78 |
| Dec 31, 2020 | -0.79 |
| Sep 30, 2020 | -0.61 |
| Jun 30, 2020 | -0.49 |
| Mar 31, 2020 | -0.88 |
| Dec 31, 2019 | -0.71 |
| Sep 30, 2019 | -0.56 |
| Jun 30, 2019 | -0.41 |
| Mar 31, 2019 | -0.32 |
| Dec 31, 2018 | -0.32 |
| Sep 30, 2018 | -0.31 |
| Jun 30, 2018 | -0.32 |
| Mar 31, 2018 | -0.19 |
| Dec 31, 2017 | -0.31 |
| Sep 30, 2017 | -0.27 |
| Jun 30, 2017 | -0.30 |
| Mar 31, 2017 | -0.41 |
| Dec 31, 2016 | -0.38 |
| Sep 30, 2016 | -0.38 |
| Jun 30, 2016 | -0.36 |
| Mar 31, 2016 | -0.31 |
| Dec 31, 2015 | -0.23 |
| Sep 30, 2015 | -0.41 |
| Jun 30, 2015 | -0.19 |
| Mar 31, 2015 | -0.19 |